Essential Medical Reading
Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
Longer overall survival and similar safety profile were the endpoints in this NEJM piece, comparing those who received osimertinib with those who received a comparator EGFR-TKI.
Internal Medicine March 16th 2020
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Can transfusion independence for multiple weeks be possible in patients with myelodysplastic syndromes? Read on to discover promising information you can share with your patients about reducing the severity of their anemia.
Hematology March 16th 2020